Ocular Therapeutix (OCUL) Shares Issued (2014 - 2026)

Ocular Therapeutix (OCUL) posted quarterly Shares Issued of $11.9 million for Q2 2026, down 37.65% on a QoQ basis from $19.1 million in Q4 2025.

Ocular Therapeutix (OCUL) Shares Issued (2014 - 2026) Analysis & Trends

Ocular Therapeutix has reported Shares Issued for 13 years, with the latest figure at $11.9 million in Q2 2026.

Shares Issued for Q2 2026 came in at $11.9 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $11.9 million (changed N/A YoY), and the FY2025 annual result was $19.1 million, down 3.77% from the prior year.
Shares Issued slipped to $11.9 million in Q2 2026, from $19.1 million in the prior quarter.
Over five years, Shares Issued peaked at $19.9 million in Q4 2024 and troughed at $398784.0 in Q4 2023.
A 5-year average of $7.6 million and a median of $6.0 million in 2023 frame the typical range for Shares Issued.
The widest annual swing landed in 2023, when Shares Issued slumped 97.08%; it then jumped 4887.08% in 2024.
A 5-year view of Shares Issued shows it stood at $13.7 million in 2022, then slumped by 97.08% to $398784.0 in 2023, then jumped by 4887.08% to $19.9 million in 2024, then slipped by 3.77% to $19.1 million in 2025, then plunged by 37.65% to $11.9 million in 2026.
Per Business Quant data, the three most recent Shares Issued figures were $11.9 million in Q2 2026, $19.1 million in Q4 2025, and $2.3 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	18.36 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Ocular Therapeutix	2.20 Bn	2.20 Bn	11.46 Mn	11.93 Mn

Download Data